Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

FDA Considers Alternative Flu Vaccine Production Methods

  • Post author:Sam
  • Post published:February 27, 2018
  • Post category:Drug Industry Daily

Researchers at the FDA and the Centers for Medicare and Medicaid Services are considering whether a cell-based influenza vaccine might be more effective than the egg-based vaccine that did not…

Continue ReadingFDA Considers Alternative Flu Vaccine Production Methods

DOJ Plans Opioid Task Force and Will Join in Multidistrict Opioid Suits

  • Post author:Sam
  • Post published:February 27, 2018
  • Post category:Drug Industry Daily

The Justice Department is creating a task force to combat the opioid crisis and plans to file a Statement of Interest in multidistrict litigation against distributors and manufacturers of opioids,…

Continue ReadingDOJ Plans Opioid Task Force and Will Join in Multidistrict Opioid Suits

Incoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month. Source: BioSpace

Continue ReadingIncoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry

Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory …

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

Aldeyra Therapeutics has signed a collaboration research deal with Janssen Research & Development, a Johnson & Johnson company. Source: BioSpace

Continue ReadingAldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory …

DBV Technologies Reports Positive Data from Milk Allergy Trial

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

French company DBV Technologies is seeing some positive results from its milk allergy treatment. Source: BioSpace

Continue ReadingDBV Technologies Reports Positive Data from Milk Allergy Trial

Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

Cambridge, Massachusetts-based Generation Bio closed on a $100 million Series B financing today. Source: BioSpace

Continue ReadingGeneration Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program

Senti Biosciences Raises $53 Million from Amgen and Others in Series A Financing

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

Senti Biosciences, based in South San Francisco, has completed a $53 million Series A financing. Source: BioSpace

Continue ReadingSenti Biosciences Raises $53 Million from Amgen and Others in Series A Financing

Eli Lilly’s Verzenio Picks Up Third Approved Indication

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:BioPharma

Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace

Continue ReadingEli Lilly’s Verzenio Picks Up Third Approved Indication

A&Z Pharmaceutical Cited for Calibration and Batch Deficiencies

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:Drug Industry Daily

The FDA issued A&Z Pharmaceutical a Form 483 for deficiencies at its Hauppauge, New York facility that included improper storage conditions, poor calibration practices and failure to review batch failures.…

Continue ReadingA&Z Pharmaceutical Cited for Calibration and Batch Deficiencies

DOJ Files False Claims Act Complaint Against Compounder

  • Post author:Sam
  • Post published:February 26, 2018
  • Post category:Drug Industry Daily

The U.S. Department of Justice filed a complaint against Patient Care America, a Pompano Beach, Florida compounding pharmacy, claiming the firm made illegal payments to secure prescriptions for drugs reimbursed…

Continue ReadingDOJ Files False Claims Act Complaint Against Compounder
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 26
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company